Invitrogen™ Equine VEGF-A ELISA Kit

Ref.: BL-RE-090895Manufacturer ref.: EE9RBX5 5 x 96 tests
€2,950.00 excl. VAT

Equine VEGF-A quantitates equine VEGF-A in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant equine VEGF-A.

Accession number
Facteur angiogénique ; ETID309976.16 ; eVEGF120 ; eVEGF164 ; homologue VEGF121 humain ; MGC70609; MVCD1; facteur de croissance endothéliale vasculaire de l’ovine; RP1-261G23.1; produit protéique sans nom; VAS; facteur de croissance endothélial vasculaire; précurseur du facteur de croissance endothélial vasculaire (VEGF); isoforme du facteur de croissance endothélial vasculaire 121; facteur de croissance endothélial vasculaire 164; facteur de croissance endothélial vasculaire 165 b; facteur de croissance endothélial vasculaire 182 isoforme; facteur de croissance endothélial vasculaire 188; facteur de croissance 188; Facteur de croissance endothélial vasculaire 188 isoforme; facteur de croissance endothélial vasculaire 189; facteur de croissance endothélial vasculaire A; facteur de croissance endothélial vasculaire A121; facteur de croissance endothélial vasculaire A165; facteur de croissance endothélial vasculaire Aa; facteur de croissance endothélial vasculaire
Dose range
4 to 1 000 pg/mL
Sensitivity of the dosage
4 pg/mL
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Equine VEGF-A quantitates equine VEGF-A in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant equine VEGF-A.

Equine VEGF-A quantitates equine VEGF-A in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant equine VEGF-A.

VEGF (vascular endothelial growth factor) is a homodimer glycoprotein with disulfide bridges involved in angiogenesis, which promotes tumour progression and metastases. VEGF has a variety of effects on vascular endothelium, including the ability to promote endothelial cell viability, mitogenesis, chemotaxia and vascular permeability. The VEGF family currently includes VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E, and PIGF. VEGF and its receiving system are the fundamental regulators in the cellular signalling of gastrointestinal genesis. Most tumours have absolute requirement for benzogenesis, and VEGF has been described as the most potent angiogenic cytokine associated with this process. To date, 5 different VEGF isoforms have been described. These isoforms are generated following an alternative splicing from a single VEGF gene. These various isoforms have been shown to bind to two tyrosine kinase flt-1 receptors (VEGFR-1) and FLK-1/KDR (VEGFR-2) receptors, which have been expressed almost exclusively on endothelial cells. VEGF and its high affinity binding receptors, tyrosine kinases FLK1 and FLT1, are considered important for the development of embryonic vasculature. Studies have shown that an alternately spliced form of FLT1 produces a soluble protein, called sFLT1, which binds the high affinity vascular endothelial growth factor, which plays an inhibitory role in angiogenesis. High levels of VEGF are related to POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, skin changes) also known as Cro-Fukase syndrome, which affects several organs in the body.

Sensitivity

Sensitivity of the dosage: 4 pg/mL.

Measurement range

Dose range: 4 to 1,000 pg/mL.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Samples

Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).

Conjugate

Conjugated: Biotin.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17154829
Specifications
Accession numberAngiogenic factor; ETID309976.16; eVEGF120; eVEGF164; homologue VEGF121 human; MGC70609; MVCD1; vascular endothelial growth factor of l的ovine; RP1-261G23.1; nameless protein product; VAS; vascular endothelial growth factor; precursor of endothelial growth factor
Dose range4 to 1 000 pg/mL
Sensitivity of the dosage4 pg/mL
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)Q9GKR0
Gene symbol(s)VEGFA analysis
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kitsPre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusUse exclusively for research
TargetVEGF analysis
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 50 µl; plasma, 50 µl; supernatant, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EE9RBX5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.